All posts
-
Ubicept Showcases Physics-Based Imaging at CES 2026 to Usher in the Next Generation of Smart Perception for Robotics and Autonomous Vehicles | RoboticsTomorrow
Ubicept Showcases Physics-Based totally mostly Imaging at CES 2026 to Usher in the Subsequent Abilities of Effectively-organized Perception for Robotics and Self sustaining Vehicles Following the delivery of the Ubicept Toolkit, the computer imaginative and prescient startup demonstrates reductions in blur and noise on CMOS and SPAD sensors for clearer and extra respectable imagery Ubicept
-
Qualcomm Introduces a Full Suite of Robotics Technologies, Powering Physical AI from Household Robots up to Full-Size Humanoids | RoboticsTomorrow
Qualcomm Introduces a Beefy Suite of Robotics Technologies, Powering Physical AI from Household Robots up to Beefy-Dimension Humanoids Utilizing management in Physical AI with comprehensive stack systems built on security-grade high performance SoC platforms, Qualcomm’s frequent-reason robotics architecture delivers industry-main vitality efficiency and scalability, enabling capabilities from private provider robots to next technology industrial self
-
Where Robotics Is Headed: RealSense Identifies the 5 Trends Defining Robotics in 2026 | RoboticsTomorrow
Where Robotics Is Headed: RealSense Identifies the 5 Trends Defining Robotics in 2026 Trusty-world deployments across CES repeat how perception is changing into the root of autonomy, from AMRs to humanoids CES 2026 —As robots hotfoot from novelty to necessity across factories, warehouses, hospitals, and public areas, CES 2026 is making one thing clear: visual
-
南海プライウッド、インドネシア・ジャワ州に新工場稼働 13億円投資
. 3820132021 […].
-
Monadelphous lands bumper A$175M dumper deal with BHP
Monadelphous improves its enduring partnership with BHP .
-
Milestone payments are uncertain in life sciences: Only 9.5% are paid out
Due to the substantial unpredictability bordering landmark settlements, Danish life scientific research funds are dealing with difficult to protect the biggest feasible in advance …
-
Orifarm recruits new head of business development from Hamburg
Orifarm’s brand-new elderly administration ash, Jutta Schnirring-Mayer, will certainly speed up the development of Orifarm’s generics service in Europe.
-
US FDA grants priority review for Sanofi’s type 1 diabetes drug
France is looking for fast-track authorization of diabetes mellitus medicine Tzield in youngsters matured over one.
-
Novo Nordisk rolls out introductory offer on new weight loss pill
The initial deal of USD 149 relates to the reduced dosages of the Wegovy tablet.
-
Despite chaos in the US, M&A professionals foresee surge in corporate transactions: “We are facing a boom”
Medicinalselskabernes omfattende patentkløfter sætter turbo M&A- markedet, guys kampen om fremtidens lægemidler vil skrue op for priserne i 2026, spår M&A- people.
